UMB298
Modify Date: 2025-09-19 13:20:49
UMB298 structure
|
Common Name | UMB298 | ||
|---|---|---|---|---|
| CAS Number | 2266569-73-5 | Molecular Weight | 479.01 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C27H31ClN4O2 | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of UMB298UMB298 is a potent and selective CBP/P300 bromodomain inhibitor[1]. |
| Name | UMB298 |
|---|
| Description | UMB298 is a potent and selective CBP/P300 bromodomain inhibitor[1]. |
|---|---|
| Related Catalog | |
| Target |
BRD4:5193 nM (IC50) |
| In Vitro | UMB298 (0.01~10 μM; 50 days; MOLM13 and MM cells) inhibits cells growth[1]. UMB298 (1~10 μM; 2 hours; MOLM13 cells) reduces the H3K27ac level similar to CBP30 and causes MYC depletion as a signature of CBP inhibition in acute myeloid leukemia[1]. UMB298 (3 μM; 2hours; MOLM13 cells) down-regulates MYC expression[1]. Cell Viability Assay[1] Cell Line: MOLM13 and MM cells Concentration: 0.01~10 μM Incubation Time: 50 days Result: Inhibited cells growth. Western Blot Analysis[1] Cell Line: MOLM13 cells Concentration: 1~10 μM Incubation Time: 2 hours Result: Reduced the H3K27ac level similar to CBP30 and caused MYC depletion as a signature of CBP inhibition in acute myeloid leukemia. RT-PCR[1] Cell Line: MOLM13 cells Concentration: 3 μM Incubation Time: 2 hours Result: Down-regulated MYC expression. |
| References |
| Molecular Formula | C27H31ClN4O2 |
|---|---|
| Molecular Weight | 479.01 |
| InChIKey | NZXSWCLCRDCHGN-UHFFFAOYSA-N |
| SMILES | COc1ccc(CCc2nc3cc(-c4c(C)noc4C)ccn3c2NC2CCCCC2)cc1Cl |